Dr. Halpern is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
18 E 41st St
Fl 14
New York, NY 10017Phone+1 917-503-9148Fax+1 833-449-4351
Summary
- Dr. Joshua Halpern MD MS is a board-certified and fellowship-trained Reproductive Urologist practicing in New York and throughout the Northeast. He serves as both the Regional Medical Director in the Northeast and Chief Scientific Officer for Posterity Health. He is also on faculty at Northwestern University Feinberg School of Medicine.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 2013 - 2018
Weill Cornell Graduate School of Medical SciencesMS, Health Policy and Economics, 2015 - 2016- New York Presbyterian Hospital (Cornell Campus)Internship, Surgery, 2012 - 2013
Weill Cornell MedicineClass of 2012, MD, Alpha Omega Alpha
Certifications & Licensure
IL State Medical License 2018 - 2026
MA State Medical License 2023 - 2026
ME State Medical License 2023 - 2026
RI State Medical License 2024 - 2026
VT State Medical License 2023 - 2026
CO State Medical License 2024 - 2025
CT State Medical License 2023 - 2025- American Board of Urology Urology
- Join now to see all
Publications & Presentations
PubMed
- 42 citationsDecline in Serum Testosterone Levels Among Adolescent and Young Adult Men in the USASoum D. Lokeshwar, Premal Patel, Richard J. Fantus, Joshua A. Halpern, Cecilia Chang
European Urology Focus. 2021-07-01 - 38 citationsLaser Vaporization of the Prostate With the 180-W XPS-Greenlight Laser in Patients With Ongoing Platelet Aggregation Inhibition and Oral AnticoagulationDaniel J. Lee, Malte Rieken, Joshua A. Halpern, Fujun Zhao, Heike Pueschel
Urology. 2016-05-01 - 52 citationsNational trends in management of localized prostate cancer: A population based analysis 2004-2013.Junchao Chen, Clara Oromendia, Joshua A. Halpern, Karla V. Ballman
The Prostate. 2018-03-14
Press Mentions
Are GLP-1s the Newest Fertility Treatment?November 8th, 2024- Direct-to-Consumer Online Platforms Expand Access, but Often Fail to Convey Risks of Testosterone TherapyDecember 5th, 2022
- Health News | Online Platforms Give Access to Testosterone Therapy Without Caution: StudyDecember 5th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
